Hematology

Filter

CRISPR gene therapy

CRISPR Gene Therapy Shows Promise in Sickle Cell Disease

May 2026

CRISPR gene therapy shows improved haemoglobin levels and reduced vaso occlusive events in severe sickle cell disease in early phase study data.

Study Finds Donor Choice Influences Haploidentical Stem Cell Transplant Success

Donor age and cell dose significantly influence outcomes in haploidentical stem cell transplants, reveals new research.

Study Finds Sickle Cell Trait Not Linked to Exertion-Related Death

New research finds no evidence linking sickle cell trait to acute pain crises or sudden death during exertion.

Daratumumab-Based Quadruplet Regimen Sets New Benchmark in Myeloma Treatment

A Phase III trial shows adding daratumumab to VRd enhances treatment response in transplant-ineligible multiple myeloma patients.

Nonselective β-Blocker Use Linked to Mortality After Stem Cell Transplantation

Nonselective β-blockers may impair haematopoietic regeneration after transplantation, particularly with post-transplant chemotherapy.

Genetic Analysis of 527 Cases of Rare Bleeding Disorders: EAHAD 2025

Genetic analysis of 527 rare bleeding disorder cases reveals novel variants, according to research presented at the EAHAD 2024 Annual Congress.

Reclassification of Haemophilia Carriers Improves Diagnosis and Care: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, a new system improves diagnosis and care for hemophilia carriers.

miRNA Signatures as Biomarkers for Haemophilic Arthropathy: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, miRNA signatures could serve as biomarkers for hemophilic arthropathy.

Emerging Risks of Spinal Stenosis in Older People with Haemophilia: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, spinal stenosis is increasingly common in aging hemophilia patients.

Loading posts...

« Previous 1 … 18 19 20 21 22 … 49 Next »